Immune Design's Unattributed - II Round

Immune Design raised a round of funding on June 12, 2014.

Immune Design is a clinical-stage biotechnology company developing two synergistic platforms of next-generation vaccines designed to treat cancer, infectious diseases, allergy, and autoimmune disorder…

Articles about Immune Design's Unattributed - II Round: